logo
Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137
rus
русский
eng
english

Site search



Correspondence address
310 Mira Street, Stavropol, Russia, 355017

Tel
+7 8652 352524; +7 8652 353229.

Fax
+7 8652 352524.

E-mail
medvestnik@stgmu.ru

Supranational (international) guidelines for management of the heart structural anomalies


Andrey Rudoy;

Supranational (international) Guidelines for Management of the Heart Structural Anomalies were developed by the expert committee of Eurasian Association of Internists, Belarusian Scientific Society of Cardiologists and Russian Scientific Medical Society of Internal Medicine, and approved by the II Congress of the Eurasian Association of Internists on 19–20 May 2016 (Yerevan), as well as by the VII Congress of Cardiologists, Cardiosurgeons, X-ray Endovascular and Vascular Surgeons of the Republic of Belarus on 15–16 December 2016 (Minsk).

Download

References:
1. Zemtsovskii E. V., Malev E. G. Malye anomalii serdtsa i displasticheskie fenotipy. SPb.: Izd-vo «IVESEP», 2012. (In Russ.)
2. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. Eur. Heart J. 2014;1;35(41):2873-2926. https://doi.org/10.1093/eurheartj/ehu281
3. Silvestry F. E., Cohen M. S., Armsby L. B. [et al.]. Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. Journal of the American Society of Echocardiography. 2015;28(8):910-958. https://doi.org/10.1016/j.echo.2015.05.015
4. Kadurina T I., Gorbunova V. N. Displaziya soedinitel’noj tkani: Rukovodstvo dlya vrachej. SPb.: «E’lbi-SPb», 2009. (In Russ.)
5. Nexajchik T. A. Ge- modinamicheskoe obespechenie pokoya i fizicheskoj na- gruzki u molodyx muzhchin s malymi anomaliyami serdca: dis. 2009. (In Russ.)
6. Baranova A. V., Skobeeva A. V., Skoblov M. Ju. Glava 1 - Genom cheloveka. Nasledstvennye bolezni: nacional’noe rukovodstvo. pod red. akad. RAMN N. P Bochkova, akad. RAMN E. K. Gintera, akad RAMN V. P Puzyreva. Moskva: «GJeOTAR-Media», 2012. (In Russ.)
7. Nishimura R. A., Otto C. M., Bonow R. O. [et al.]. AHA/ ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology. American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2014;63(22):2438- 2488. https://doi.org/10.1016/jJacc.2014.02.537
8. Authors Task Force Members, Vahanian A., Alfieri O., Andreotti F. [et al.]. Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 2012;33(19):2451-2496. https://doi.org/10.1093/eu-rheartj/ehs109
9. Lang R. M., Badano L. P, Mor-Avi V. [et al.]. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echo- cardiogr. 2015;28(1):1-39. https://doi.org/10.1016/j.echo.2014.10.003
10. Porter T R., Abdelmoneim S., Belcik J. T [et al.]. Guidelines for the cardiac sonographer in the performance of contrast echocardiography: a focused update from the American Society of Echocardiography. Journal of the American Society of Echocardiography. 2014;27(8);797-810. https://doi.org/10.1016Zj.echo.2014.05.011
11. Loeys B. L., Dietz H. C., Braverman A. C. [et al.]. The revised Ghent nosology for the Marfan syndrome. Journal of Medical Genetics. 2010;47(7):476-485. https://doi.org/10.1136/jmg.2009.072785
12. Beighton P, De Paepe A., Steinmann B. [et al.]. Ehlers Danlos syndromes: Revised nosology, Villefranche, 1997. American Journal of Medical Genetics. 1998;77(1):31- 37.
13. Grahame R. The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). J. Rheumatol. 2000;27:1777-1779.
14. Zemcovskij E. V. Nasledstvennye narusheniya soedinitel’noj tkani v kardiologii. Diagnostika i lechenie: Rossijskie rekomendacii (I peresmotr). Ros. kardiolog. obshh-vo; kom. e’kspertov. Ros. kard. zhur- nal. - Russian Cardiology Journal. 2013;99(1):32. (In Russ.)
15. Martynov A. I., Nechaeva G. I., Akatova E. V. [et al.]. Nacional’nye rekomendacii Rossijskogo nauchnogo medicinskogo obshhestva terapevtov po diagnostike, lecheniyu i reabilitacii pacientov s displaziyami soedinitel’noj tkani. Medicinskii vestnik Severnogo Kavkaza. - Medical News of North Caucasus. 2016;11(1):2-76. (In Russ.) https://doi.org/10.14300/mnnc.2016.11001
16. Kadurina T. I., Gnusaev S. F., Abbakumova L. N. [et al.]. Nasledstvennye i mnogofaktornye narusheniya soedinitel’noj tkani u detej algoritmy diagnostiki. Taktika vedeniya proekt rossijskix rekomendacij razrabotan komitetom e’kspertov pediatricheskoj gruppy «Displaziya soedinitel’noj tkani» pri rossijskom nauchnom obshhestve terapevtov. Medicinskii vestnik Severnogo Kavkaza. - Medical News of North Caucasus. 2015;10(1):5-35. (In Russ.) https://doi.org/10.14300/mnnc.2015.10001
17. Diagnostika i lechenie nasledstvennyx i mul’tifaktorial’nyx narushenij soedinitel’noj tkani. Nacional’nye klinicheskie rekomendacii. Minsk: «Professional’nye izdaniya», 2015. (In Russ.)
18. Martynov A. I., Jakovlev V. M., Nechaeva G. I. [et al.]. Diagnostika i taktika vedenija pacientov s displaziej soedinitel’noj tkani v uslovijah pervichnoj mediko-sanitarnoj pomoshhi. Metodicheskie rekomendacii dlja vrachej. Omsk, 2013. (In Russ.)
19. Nechaeva G. I., Konev V. P, Druk I. V. Vyjavlenie i taktika vedenija pacientov s nedifferencirovannoj displaziej soedinitel’noj tkani. Prakticheskoe rukovodstvo dlja vrachej/pod red. A. I. Martynova. 2011. (In Russ.)
20. Storozha- kov G. I., Gendlin G. E., Miller O. A. Bolezni klapanov serd- ca. M.: «Praktika», 2012. (In Russ.)
21. Homma S. Patent Foramen Ovale and Stroke. Circulation. 2005;112(7):1063-1072. https://doi.org/10.1161/circu- lationaha.104.524371
22. Meissner I., Khandheria B. K., Heit J. A. [et al.]. Patent foramen ovale: innocent or guilty?: evidence from a prospective population-based study. Journal of the American College of Cardiology. 2006;47(2):440-445. https://doi.org/10.1016/jJacc.2005.10.044
23. Petty G. W., Khandheria B. K., Meissner I. [et al.]. Population-based study of the relationship between patent foramen ovale and cerebrovascular ischemic events. Mayo Clin Proc. 2006;81:602-608. https://doi.org/10.4065/81.5.602
24. Di Tullio M. R., Sacco R. L., Sciacca R. R. [et al.]. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J. Am. Coll. Cardiol. 2007;49:797-802. https://doi.org/10.1016/jJacc.2006.08.063
25. Onishhenko E. F. Otkrytoe oval’noe okno i insul’t v klinich- eskoj praktike. SPb: «JeLBI-SPb», 2005. (In Russ.)
26. Davison P, Clift P F., Steeds R. P The role of echocardiography in diagnosis, monitoring closure and post-procedural assessment of patent foramen ovale. European Journal of Echocardiography. 2010;11(10):127-134. https://doi.org/10.1093/ejechocard/jeq120
27. Calvert P A., Rana B. S., Kydd A. C., Shapiro L. M. Patent foramen ovale: anatomy, outcomes, and closure. Nat. Rev. Cardiol. 2011;8(3):148-160. https://doi.org/10.1038/nr-cardio.2010.224
28. Guercini F., Acciarresi M., Agnelli G. [et al.]. Cryptogenic stroke: time to determine aetiology. 2008;6(4):549-554. https://doi.org/10.1111/j.1538-7836.2008.02903.x
29. Palomeras E. S., Fossas P F., Cano A. O. [et al.]. Cryptogenic infarct. A follow-up period of 1 year study. Neurologia (Barcelona, Spain). 2009;24(5):304-308.
30. Alsheikh-Ali A. A., Thaler D. E., Kent D. M. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke. 2009;40(7):2349-2355. https://doi.org/10.1161/strokeaha.109.547828
31. Ivanickij A. V., Goluhova E. Z., Kosenko A. I. Otkrytoe oval’noe okno: rol’ v patogeneze rjada nevrologicheskih zabolevanij i metody ih lechenija. Zhurnal nevrologii i psihiatrii. - Journal of Neurology and Psychiatry. 2014;5:65-68. (In Russ.)
32. Suslina Z. A., Fonjakin A. V., Chechet- kin A. O. Patogeneticheskaja geterogennost’ ishemi- cheskogo insul’ta i otkrytoe oval’noe otverstie. Kliniches- kaja nevrologija. - Clinical neurology. 2008;3(2):4-7. (In Russ.)
33. Diener H. C., Easton J. D., Granger C. B. [et al.]. Rationale, objectives and design of a secondary stroke prevention study of dabigatran etexilate versus acetyl- salicylic acid in patients with embolic stroke of undetermined source (RE-SPECT-ESUS). International Journal of Stroke. 2014;9:216.
34. Srivastava T. N., Payment M. F. Paradoxical embolism- thrombus in transit through a patent foramen ovale. New England Journal of Medicine. 1997;337(10):681. https://doi.org/10.1056/nejm199709043371005
35. Hart R. G., Diener H. C., Coutts S. B. [et al.]. Cryptogenic Stroke/ESUS International Working Group. Embolic strokes of undetermined source: the case for a new clinical construct. The Lancet Neurology. 2014;13(4): 429-438.
36. Di Tullio M., Sacco R. L., Venketasubramanian N. [et al.]. Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke. 1993;24(7):1020-1024.
37. Cramer S. C., Rordorf G., Maki J. H. [et al.]. Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke. 2004;35(1):46-50. https://doi.org/10.1161/01.str.0000106137.42649.ab
38. Scarvelis D., Wells P. S. Diagnosis and treatment of deep- vein thrombosis. Canadian Medical Association Journal. 2006;175(9):1087-1092. https://doi.org/10.1503/cmaj.060366
39. Meier B. Closure of patent foramen ovale: technique, pitfalls, complications, and follow up. Heart. 2005;91(4):444- 448. https://doi.org/10.1136/hrt.2004.052258
40. Overell J. R., Bone I., Lees K. R. [et al.]. Interatrial septal abnormalities and stroke. A meta-analysis of case-control studies. Neurology. 2000;55(8):1172-1179. https://doi.org/10.1212/wnl.55.8.1172
41. Caputi L., Usai S., Carriero M. R. [et al.]. Microembo- lic Air Load During Contrast Transcranial Doppler: A Trigger for Migraine With Aura? Headache: The Journal of Head and Face Pain. 2010;50(8):1320-1327. https://doi.org/10.1111/j.1526-4610.2010.01621.x
42. Karttunen V., Hiltunen L., Rasi V. [et al.]. Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale. Blood coagulation & fibrinolysis. 2003;14(3):261-268. https://doi.org/10.1097/01.mbc.0000061288.28953.c8
43. Bezzi G., Bolzani W., Compagnoni V. [et al.]. Factor V Leiden mutation and patent foramen ovale in ischemic stroke. Neurological Sciences. 2002;23(5):229-231. https://doi.org/10.1007/s100720200046
44. Carod-Artal F. J., Vilela S. N., Portugal D. Thrombophilia and patent foramen ovale in young stroke patients. Neurologia (Barcelona, Spain). 2006;21(10):710-716. https://doi.org/10.1111/j.1468-2982.2006.01156.x
45. Sastry S., Riding G., Morris J. [et al.]. Young Adult Myocardial Infarction and Ischemic Stroke: the role of paradoxical embolism and thrombophilia (The YAMIS Study). Journal of the American College of Cardiology. 2006;48(4):686- 691. https://doi.org/10.1016/jJacc.2006.02.074
46. Jauch E. C., Saver J. L., Adams H. P Jr. [et al.]. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association. American Stroke Association. Stroke. 2013;44(3):870-947. https://doi.org/ 10.1161/STR.0b013e318284056a
47. Kernan W. N., Ovbiagele B., Black H. R. [et al.]. Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association. American Stroke Association. Stroke. 2014;45(7):2160-2236. https://doi.org/10.1161/str.0000000000000024
48. Burchell H. B. Reflect orthostatic dyspnea associated with pulmonary hypotension. Am. J. Physiol. 1949;159:563-564.
49. Cheng T. O. Platypnea orthodeoxia syndrome: etiology, differential diagnosis, and management. Catheterization and Cardiovascular Interventions. 1999;47(1):64-66. https://doi.org/10.1002/(SICI)1522-726X(199905)47:13.0.CO;2-6
50. Medina A., de Lezo J. S., Caballero E. [et al.]. Platy-pnea-orthodeoxia due to aortic elongation. Circulation. 2001;104(6):741-741. https://doi.org/10.1161/hc3101.093603
51. Pinto F. J. When and how to diagnose patent foramen ovale. Heart. 2005;91(4):438-440. https://doi.org/10.1136/hrt.2004.052233
52. Sommer R. J., Hijazi Z. M., Rhodes J. F. Pathophysiology of Congenital Heart Disease in the Adult: Part I: Shunt Lesions. Circulation. 2008;117(8):1090-1099. https://doi.org/10.1161/circulationaha.107.714402
53. Torti S. R., Billinger M., Schwerzmann M. Risk of decompression illness among 230 divers in relation to the presence and size of patent foramen ovale. ACC Current Journal Review. 2004;13(10):25. https://doi.org/10.1016Zj.accreview.2004.08.065
54. Sharykin А. S. Patent foramen ovale - small abnormality or heart defect? Pediatriya. - Pediatrics. 2013;1:24-27. (In Russ.)
55. Mojadidi M. K., Bogush N., Caceres J. D. [et al.]. Diagnostic Accuracy of Transesophageal Echocardiogram for the Detection of Patent Foramen Ovale: A Meta-Analysis. Echocardiography. 2013;31(6):752-758. https://doi. org/10.1111/echo.12462
56. Buchholz S., Shakil A., Figtree G. A. [et al.]. Diagnosis and management of patent foramen ovale. Postgraduate Medical Journal. 2012;88(1038):217-225. https://doi.org/10.1136/postgradmedj-2011-130368
57. Tanaka J., Harada K., Izumo M. [et al.]. Classification of Patent Foramen Ovale Tunnel Morphology; A Real Time 3-Dimentional Transesophageal Echocardiographic Study. Circulation. 2012;126(21):A16788.
58. Newton J. D., Mitchell A. R. J., Wilson N. [et al.]. Intracardiac Echocardiography for Patent Foramen Ovale Closure: Justification of Routine Use. JACC: Cardiovascular Interventions. 2009;2(4):369. https://doi.org/10.1016/j.jcin.2009.02.005
59. Yared K., Baggish A. L., Solis J. [et al.]. Echocardiographic Assessment of Percutaneous Patent Foramen Ovale and Atrial Septal Defect Closure Complications. Circulation: Cardiovascular Imaging. 2009;2(2):141-149. https://doi.org/10.1161/circimaging.108.832436
60. Gonzalez-Alujas T., Evangelista A., Santamarina E. [et al.]. Diagnosis and Quantification of Patent Foramen Ovale. Which Is the Reference Technique? Simultaneous Study With Transcranial Doppler, Transthoracic and Transesophageal Echocardiography. Revista Espanola de Cardiologia (English Edition). 2011;64(2):133-139. https://doi.org/10.1016/j.rec.2010.10.014
61. Sharykin A. S. Vrozhdyonnye poroki serdca. Rukovodstvo dlya pedi- atrov, kardiologov, neonatologov. 2 izd. M.: «BINOM», 2009. (In Russ.)
62. Touboul P. J., Elbaz A., Koller C. [et al.]. GENIC Investigators. Common carotid artery intima-media thickness and brain infarction: the Etude du Profil Genetique de l’Infarctus Cerebral (GENIC) case-control study. Circulation. 2000;102(3):313-318. https://doi.org/10.1161/01.CIR.102.3.313
63. Suslina Z. A., Vereshhagin N. V., Piradov M. A. Podtipy ishemicheskix narushenij mozgov- ogo krovoobrashheniya: diagnostika i lechenie. Consilium medicum. 2001;3(5):218-221. (In Russ.)
64. Adams H. P., Bendixen B. H., Kappelle L. J. [et al.]. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35- 41. https://doi.org/10.1161/01.str.24.1.35
65. Finsterer J. Management of cryptogenic stroke. Acta Neurol. Belg. 2010;110(2):135-147.
66. Arquizan C., Coste J., Touboul P.-J. [et al.]. Is Patent Foramen Ovale a Family Trait? : A Transcranial Doppler Sonographic Study. Stroke. 2001;32(7):1563-1566. https://doi.org/10.1161/01.str.32.7.1563
67. Thaler D. E., Saver J. L. Cryptogenic stroke and patent foramen ovale. Current Opinion in Cardiology. 2008;23(6):537-544. https://doi.org/10.1097/hco.0b013e32831311bd
68. Schuchlenz H. W., Weihs W., Horner S. [et al.]. The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. The American Journal of Medicine. 2000;109(6):456-462. https://doi.org/10.1016/s0002-9343(00)00530-1
69. Messe S. R., Silverman I. E., Kizer J. R. [et al.]. Practice Parameter: Recurrent stroke with patent foramen ovale and atrial septal aneurysm: [RETIRED]. Neurology. 2004;62(7):1042-1050. https://doi.org/10.1212/01.wnl.0000119173.15878.f3
70. Arauz A., Murillo L., Marquez J. M. [et al.]. Long-Term Risk of Recurrent Stroke in Young Cryptogenic Stroke Patients with and without Patent Foramen Ovale. International Journal of Stroke. 2011;7(8):631-634. https://doi.org/10.1111/j.1747-4949.2011.00641.x
71. Mas J.-L., Arquizan C., Lamy C. [et al.]. Recurrent Cerebrovascular Events Associated with Patent Foramen Ovale, Atrial Septal Aneurysm, or Both. New England Journal of Medicine. 2001;345(24):1740-1746. https://doi.org/10.1056/nejmoa011503
72. Lamy C., Giannesini C., Zuber M. [et al.]. Clinical and Imaging Findings in Cryptogenic Stroke Patients With and Without Patent Foramen Ovale: The PFO-ASA Study. Stroke. 2002;33(3):706-711. https://doi.org/10.1161/hs0302.104543
73. Katsanos A. H., Spence J. D., Bogiatzi C. [et al.]. Recurrent Stroke and Patent Foramen Ovale. Stroke. 2014;45(11):3352-3359. https://doi.org/10.1161/strokeaha.114.007109
74. Whitlock R. P, Sun J. C., Fremes S. E. [et al.]. Antithrombotic and Thrombolytic Therapy for Valvular Disease. Chest. 2012;141(2):e576S-e600S. https://doi.org/10.1378/chest.11-2305
75. Messe S. R., Gronseth G., Kent D. M. [et al.]. Practice advisory: Recurrent stroke with patent foramen ovale (update of practice parameter). Neurology. 2016;87(8):815- 821. https://doi.org/10.1212/wnl.0000000000002961
76. Furlan A. J., Reisman M., Massaro J. [et al.]. Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale. New England Journal of Medicine. 2012;366(11):991-999. https://doi.org/10.1056/nej-moa1009639
77. Meier В., Kalesan В., Mattle H. P. [et al.]. Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism. New England Journal of Medicine. 2013;368(12):1083- 1091. https://doi.org/10.1056/nejmoa1211716
78. Carroll J. D., Saver J. L., Thaler D. E. [et al.]. Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke. New England Journal of Medicine. 2013;368(12):1092-1100. https://doi.org/10.1056/nej-moa1301440
79. Sacco R. L., Prabhakaran S., Thompson J. L. P. [et al.]. Comparison of Warfarin versus Aspirin for the Prevention of Recurrent Stroke or Death: Subgroup Analyses from the Warfarin-Aspirin Recurrent Stroke Study. Cerebrovascular Diseases. 2006;22(1):4-12. https://doi.org/10.1159/000092331
80. Homma S. Effect of Medical Treatment in Stroke Patients With Patent Foramen Ovale: Patent Foramen Ovale in Crypto- genic Stroke Study. Circulation. 2002;105(22):2625-2631. https://doi.org/10.1161/01.cir.0000017498.88393.44
81. Ten Hove M., Mohr J. P., Thompson J. L. P., Lazar R. M. [et al.]. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. Journal of Neuro-Ophthalmology. 2002;22(3):252. https://doi.org/10.1097/00041327-200209000-00027
82. Shariat A., Yaghoubi E., Farazdaghi M. [et al.]. Comparison of medical treatments in cryptogenic stroke patients with patent foramen ovale: a randomized clinical trial. Journal of research in medical sciences: the official Journal of Isfahan University of Medical Sciences. 2013;18(2):94.
83. Hara H., Virmani R., Ladich E. [et al.]. Patent Foramen Ovale: Current Pathology, Pathophysiology, and Clinical Status. Journal of the American College of Cardiology. 2005;46(9):1768-1776. https://doi.org/10.1016/j.jacc.2005.08.038
84. Silver M. D., Dorsey J. S. Aneurysms of the septum pri- mum in adults. Archives of pathology & laboratory medicine. 1978;102(2):62-65.
85. Zherko O. M. Malye anomalii serdca u detej. Uch.-metod. posobie. Minsk: «BelMAPO», 2007. (In Russ.)
86. Sharykin А. S. Patent foramen ovale - small abnormality or heart defect? Pediatriya. - Pediatrics. 2013;1:24-27. (In Russ.)
87. Burger A. J., Sherman H. B., Charlamb M. J. Low incidence of embolic strokes with atrial septal aneurysms: A prospective, long-term study. American Heart Journal. 2000;139(1):149-152. https://doi.org/10.1016/s0002-8703(00)90322-3
88. Nihoyannopoulos P., Kisslo J. Echocardiography. Springer Verlag, 2009. https://doi.org/10.1007/978-1-84882-293-1
89. Rybakova M. K., Alehin M. N., Mit’kov V. V. Prakticheskoe rukovodstvo po ul’trazvukovoj diagnostike. Jehokardiografija. Izd. 2-e, ispr. i dop. M.: «Izdatel’skij dom Vidar-M», 2008. (In Russ.)
90. Kuzhel D. A., Matyushin G. V., Savchenko E. A. Problems of diagnosis PFO. Cibirskoe meditsinskoe obozrenie. - Siberian medical review. 2014;1:70-75. (In Russ.)
91. Hanley P. C., Tajik A. J., Hynes J. K. [et al.]. Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: Report of 80 consecutive cases. Journal of the American College of Cardiology. 1985;6(6):1370-1382. https://doi.org/10.1016/s0735- 1097(85)80228-x
92. Olivares-Reyes A., Chan S., Lazar E. J. [et al.]. Atrial septal aneurysm: A new classification in two hundred five adults. Journal of the American Society of Echocardiography. 1997;10(6):644-656. https://doi.org/10.1016/s0894-7317(97)70027-0
93. Roudant R., Gosse R., Chague E. [et al.]. Clinical and echocardiographic feature of the aneurysm on the atrial septum in infants and adults: experiences with 44 cases. Echocardiography. 1989;6:357-362. https://doi.org/10.1111/j.1540-8175.1989.tb00316.x
94. Pearson A., Nagelhout D., Castello R. [et al.]. Atrial septal aneurysm and stroke: a transesophageal echocardio- graphic study. J. Am. Coll. Cardiol. 1991;18(122):3-9. https://doi.org/10.1016/0735-1097(91)90539-l
95. Jatav R. K. [et al.]. Atrial septal aneurysm in adult patients: spectrum of clinical, echocardiographic presentation and to propose a new classification on the basis of trans-thoracic-two-dimensional echocardiography. Int. J. Res. Med. Sci. 2014;2(2):708-717. https://doi.org/10.5455/2320-6012.ijrms20140564
96. Mugge A., Daniel W. G., Angermann C. [et al.]. Atrial septal aneurysm in adult patients. A multicenter study using transthoracic and transesophageal echocardiography. Circulation. 1995;91(11):2785-2792. https://doi.org/10.1161/01.cir.91.11.2785
97. Ghosh S., Ghosh A. K., Ghosh S. K. Patent foramen ovale and atrial septal aneurysm in cryptogenic stroke. Postgraduate Medical Journal. 2007;83(977):173-177. https://doi.org/10.1136/pgmj.2006.051094
98. Gallet B., Malergue M. C., Adams C. [et al.]. Atrial septal aneurysma potential cause of systemic embolism. An echocardiographic study. Heart. 1985;53(3):292-297. doi:10.1136/hrt.53.3.292
99. Agmon Y., Khandheria B. K., Meissner I. [et al.]. Frequecy of Atrial Septal Aneurysms in Patients With Cerebral Ischemic Events. Circulation. 1999;99(15):1942-1944. https://doi.org/10.1161/01.cir.99.15.1942
100. Janion M., Kurzawski J., Sielski J. [et al.]. Dispersion of P wave duration and P wave vector in patients with atrial septal aneurysm. EP Europace. 2007;9(7):471-474. https://doi.org/10.1093/europace/eum089
101. MATTIOLI A. P559 Mitral valve prolapse and atrial septal aneurysm in young patients with stroke and normal carotid arteries. European Heart Journal. 2003;24(5):92. https://doi.org/10.1016/s0195-668x(03)93997-2
102. Garg R., Khaja A., Madsen R. [et al.]. Observer Variation in the Echocardiographic Measurement of Maximum Atrial Septal Excursion: A Comparison of M-Mode with Two-Dimensional or Transesophageal Echocardiography. Echocardiography. 2009;26(10):1122-1126. https://doi.org/10.1111/j.1540-8175.2009.00964.x
103. Bakalli A., Kamberi L., Pllana E. [et al.]. Atrial septal aneurysm associated with additional cardiovascular comorbidities in two middle age female patients with ECG signs of right bundle branch block: two case reports. Cases Journal. 2008;1(1):51. https://doi.org/10.1186/1757- 1626-1-51
104. Anzola G. P, Giusti DEL Giardino L., Piras M. P. Patent foramen ovale (PFO) and cryptogenic stroke. Journal of Thrombosis and Haemostasis. 2010;8(8):1675-1677. https://doi.org/10.1111/j.1538-7836.2010.03887.x
105. Seiler C. How should we assess patent foramen ovale? Heart. 2004;90(11):1245-1247. https://doi.org/10.1136/hrt.2003.031500
106. Roberts W. C. Aneurysm (redundancy) of the atrial septum (fossa ovale membrane) and prolapse (redundancy) of the mitral valve. The American Journal of Cardiology. 1984;54(8):1153-1154. https://doi.org/10.1016/s0002-9149(84)80172-1
107. Iliceto S., Papa A., Sorino M. [et al.]. Combined atrial septal aneurysm and mitral valve prolapse: Detection by two-dimensional echocardiography. The American Journal of Cardiology. 1984;54(8):1151-1153. https://doi.org/10.1016/s0002-9149(84)80171-x
108. Abinader E. G., Rokey R., Goldhammer E. [et al.]. Prevalence of atrial septal aneurysm in patients with mitral valve prolapse. The American Journal of Cardiology. 1988;62(16):1139-1140. https://doi.org/10.1016/0002- 9149(88)90569-3
109. Rahko P. S., Xu Q. В. Increased prevalence of atrial septal aneurysm in mitral valve prolapse. The American Journal of Cardiology. 1990;66(2):235-237. https://doi.org/10.1016/0002-9149(90)90599-v
110. Cheng T. O. Atrial septal aneurysm as a “newly discovered” cause of stroke in patients with mitral valve prolapse. The American Journal of Cardiology. 1991;67(4):327-328. https://doi.org/10.1016/0002-9149(91)90587-b
111. Freed L. A., Levy D., Levine R. A. [et al.]. Mitral valve prolapse and atrial septal aneurysm: an evaluation in the framingham heart study. The American Journal of Cardiology. 2002;89(11):1326-1329. https://doi.org/10.1016/s0002-9149(02)02340-8
112. Lee J.-Y., Song J.-K., Song J.-M. [et al.]. Association Between Anatomic Features of Atrial Septal Abnormalities Obtained by Omni-Plane Transesophageal Echocardiography and Stroke Recurrence in Cryptogenic Stroke Patients with Patent Foramen Ovale. The American Journal of Cardiology. 2010;106(1):129-134. https://doi.org/10.1016/j.amjcard.2010.02.025
113. Rigatelli G., Dell’Avvocata F., Braggion G. [et al.]. Persistent venous valves correlate with increased shunt and multiple preceding cryptogenic embolic events in patients with patent foramen ovale: An intracardiac echocardio- graphic study. Catheterization and Cardiovascular Interventions. 2008;72(7):973-976. https://doi.org/10.1002/ccd.21761
114. Wahl A., Meier B., Schwerzmann M. [et al.]. Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients. Journal of the American College of Cardiology. 2005;45(3):377-380. https://doi.org/10.1016/j.jacc.2004.10.043
115. Greutmann M., Greutmann-Yantiri M., Kretschmar O. [et al.]. Percutaneous PFO Closure with Amplatzer PFO Occluder: Predictors of Residual Shunts at 6 Months Follow-up. Congenital Heart Disease. 2009;4(4):252-257. https://doi.org/10.1111/j.1747-0803.2009.00302.x
116. Yarovaya I. M. Organnye osobennosti gistologicheskogo stroeniya venoznyx sosudov i vozrastnye ix izmeneniya. V kn.: Ocherki po gemodinamicheskoj perestrojke sosudistoj stenki. M.: «Medicina», 1971. (In Russ.)
117. Ten S.A. K morfologii klapana nizhnej poloj veny cheloveka. 9 Vsesoyuz. s’ezd anatomov, gistologov i e’mbriologov: tez.dokl: Minsk, 1981. (In Russ.)
118. Uxov Yu. I., Kolobaev A. V. Ust’evoj klapan nizhnej poloj veny-pyatyj klapan serdca (?). Morfologiya. - Morphology. 1982;82(3):95-100. (In Russ.)
119. Laguna G., Arce N., Blanco M. Giant Chiari Network, Foramen Ovale, and Paradoxical Embolism. Revista Es- panola de Cardiologia (English Edition). 2015;68(3):250. https://doi.org/10.1016Zj.rec.2014.03.020
120. Schneider B., Hofmann T., Justen M. H. [et al.]. Chiari’s network: normal anatomic variant or risk factor for arterial embolic events? Journal of the American College of Cardiology. 1995;26(1):203-210. https://doi.org/10.1016/0735-1097(95)00144-O
121. Yudina O. A. Morfologich- eskaya i klinicheskaya xarakteristika malyx anomalij serdca: avtoref. ... dis. kand. med. nauk. Minsk, 2009. (In Russ.)
122. Alexin M. N. E’xokar- diograficheskaya diagnostika seti Xiari. Ul'trazvukovaya i funkcional'naya diagnostika. - Ultrasonic and functional diagnostics. 2014;5:119-127. (In Russ.)
123. Yater W. M. Pathologic changes in auricular fibrillation and in allied arrhythmias. Archives of Internal Medicine. 1929;43(6):808. https://doi.org/10.1001/archinte.1929.00130290079005
124. Orbison J. L. Thrombosis of anomalous chordae in the right atrium (Chiari’s network). Am. Heart J. 1949;37(1):119- 122. https://doi.org/10.1016/0002-8703(49)91435-0
125. Chevallier S., Cook S. Shoulder pain after PFO closure: look at the Chiari network. 2011. Available at: http:// ww.revespcardiol.org/en/giant-chiari-network-foramen-оvale/articulo/90387090/- Date of access: 23.01.2016.
126. Rigatelli G., DellAvvocata F., Cardaioli P. [et al.]. Migraine- Patent Foramen Ovale Connection: Role of Prominent Eustachian Valve and Large Chiari Network in Migrainous Patients. The American Journal of the Medical Sciences. 2008;336(6):458-461. https://doi.org/10.1097/maj.0b013e31816e189d
127. Payne D. M., Baskett R. J., Hirsch G. M. Infectious endocarditis of a Chiari network. The Annals of Thoracic Surgery. 2003;76(4):1303-1305. https://doi.org/10.1016/s0003-4975(03)00522-8
128. Mousavi N., Bhagirath K., Ariyarajah V. [et al.]. Chiari Network Endocarditis: Not Just an Innocent Bystander. Echocardiography. 2008;25(6):642-645. https://doi.org/10.1111/j.1540-8175.2008.00651.x
129. Latif F., Peyton M., Laszik Z. [et al.]. Infective Endocarditis of a Papillary Fibroelastoma on Chiari Network of Right Atrium: A Case Report. Journal of the American Society of Echocardiography. 2008;21(2):188.e3-188.e4. https://doi.org/10.1016/j.echo.2007.08.033
130. Koz C., Yokusoglu M., Baysan O. [et al.]. Giant Chiari network mimics intracardiac tumor in a case of neu- rofibramatosis. International Journal of Cardiology. 2008;130(3):488-489. https://doi.org/10.1016/j.ij-card.2007.05.099
131. Loukas M., Sullivan A., Tubbs R. S. [et al.]. Chiari’s network: review of the literature. Surgical and Radiologic Anatomy. 2010;32(10):895-901. https://doi.org/10.1007/s00276-010-0639-z
132. Helwig F. C. The frequency of anomalous reticula in the right atrium of the human heart “Chiari network”. Report of eight cases. Am. J. Pathol. 1932;8(1):73-79.
133. Yater W. M. The paradox of Chiari’s network: Review and report of a case of Chiari’s network ensnaring a large embolus. American Heart Journal. 1936;11(5):542-553.
134. Yuen S. T, Dickens P Sudden death from secondary massive pulmonary embolism derived from marrow emboli trapped by Chiari’s network. Forensic Sci. Int. 1992;52:211-214. https://doi.org/10.1016/0379-0738(92)90109-A
135. Powell E. D. U., Mullaney J. M. The Chiari network and the valve of the inferior vena cava. Hear. 1960;22(4):579-584. https://doi.org/10.1136/hrt.22.4.579
136. Benbow E. W., Love E. M., Love H. G. [et al.]. Massive Right Atrial Thrombus Associated with a Chiari Network and a Hickman Catheter. American Journal of Clinical Pathology. 1987;88(2):243-248. https://doi.org/10.1093/ajcp/88.2.243
137. Prajapat L., Ariyarajah V., Spodick D. H. Abnormal Atrial Depolarization Associated with Chiari Network? Cardiology. 2006;108(3):214-216. https://doi.org/10.1159/000096780
138. Alegria-Barrero E., Alegria-Barrero A., Gomez J. J. G. [et al.]. Chiari’s network and paroxysmal atrial fibrillation. Revista Espanola de Cardiologia (English Edition). 2011;64(8):727-728.
139. Teo E. Y., Ittleman F., Hamlin M. P A Chiari Network and Difficult Cannulation of the Coronary Sinus for Retrograde Perfusion. Anesthesia & Analgesia. 2010;111(1):79-81. https://doi.org/10.1213/ane.0b013e3181e05329
140. Aydin A., Gurol T, Yilmazer M. S. [et al.]. Catheter entrapment around the Chiari Network during percutaneous atrial septal defect closure. Anadolu Kardiyoloji Der- gisi. The Anatolian Journal of Cardiology. 2011;11(2). https://doi.org/10.5152/akd.2011.047
141. Goldschlager A., Goldschlager N., Brewster H. [et al.]. Catheter Entrapment in a Chiari Network Involving an Atrial Septal Defect. Chest. 1972;62(3):345-346. https://doi.org/10.1378/chest.62.3.345
142. Salmeron O., Zarco P, Nunez L. Unusual complication of right catheterization: hooking of the catheter in Chiari’s network. Archivos del Instituto de Cardiologia de Mexico. 1966;36(4):387.
143. Jain R. Nature Identical Curcumin. International Journal of Applied and Basic Medical Research. 2013;3(2):134. https://doi.org/10.4103/2229-516x.117104
144. Limacher M. C., Gutgesell H. P, Wesley Vick G. [et al.]. Echocardiographic anatomy of the eustachian valve. The American Journal of Cardiology. 1986;57(4):363-365. https://doi.org/10.1016/0002-9149(86)90930-6
145. Asirdizer M., Tatlisumak E. The role of eustachian valve and patent foramen ovale in sudden death. Journal of Clinical Forensic Medicine. 2006;13(5):262-267. https://doi.org/10.1016/j.jcfm.2005.11.009
146. Gulel O., Yazici M., Sahin M. Unusual Elongation of the Eustachian Valve. International Heart Journal. 2007;48(1):113-116. https://doi.org/10.1536/ihj.48.113
147. Ul’trazvukovaja semiotika i diagnostika v kardiologii detskogo vozrasta. Available at:www.mks.ru/library/books/bum/kni- ga01/glava_13.htm. Accessed January 10, 2016. (In Russ.)
148. 3D echocardiography: the art of defining cardiac morphology. Available at: www.3dechocardiography.com/ Cortriatriatum_Dexter.html. Accessed January 24, 2016.
149. Vale T A., Newton J. D., Orchard E. [et al.]. Prominence of the Eustachian valve in paradoxical embolism. European Journal of Echocardiography. 2010;12(1):33-36. https://doi.org/10.1093/ejechocard/jeq100
150. Schuchlenz H. W., Saurer G., Weihs W. [et al.]. Persisting eustachian valve in adults: relation to patent foramen ovale and cerebrovascular events. Journal of the American Society of Echocardiography. 2004;17(3):231-233. https://doi.org/10.1016/j.echo.2003.12.003
151. Barriales Alvarez V., Alvarez Tamargo J. A., Garcia Agua- do M. [et al.]. Trombo flotante sobre la valvula de Eus- taquio como complicacion de la enfermedad trombo- embolica venosa. Medicina Clinica. 2002;119(12):479. https://doi.org/10.1016/s0025-7753(02)73466-0
152. Jolly N., Kaul U. A., Khalilullah M. Right atrial thrombus over eustachian valve - successful lysis with streptokinase. International Journal of Cardiology.1991;30(3):354-356. https://doi.org/10.1016/0167-5273(91)90016-i
153. Maddury J., Alla V. M., Misra R. C. [et al.]. Thrombus on the eustachian valve leading to recurrent pulmonary embolism: A rare problem requiring aggressive management. Canadian Journal of Cardiology. 2009;25(12):e422- e423. https://doi.org/10.1016/s0828-282x(09)70537-9
154. Suchato C., Kitiyakara K., Arkrawong K. Suprahepatic membranous obstruction of inferior vena cava. Journal of the Canadian Association of Radiologists. 1977;28(2):148-149.
155. Schmid E., Scheule A., Locke A. [et al.]. Echocardio- graphic-Guided Placement of Venous Cannula Due to Inferior Vena Cava Obstruction Through a Large Eustachian Valve. Anesthesia & Analgesia. 2010;111(1):76-78. https://doi.org/10.1213/ane.0b013e3181e05310
156. Kokkonen L., Anttonen O., Voutilainen S. [et al.]. Central cyanosis and persisting eustachian valve. Duodecim; laa- ketieteellinen aikakauskirja. 2005;121(3):311.
157. Condoluci C., Di Donato R. M., Marcelletti C. [et al.]. Central cyanosis in a newborn infant due to a prominence of the eustachian valve. Giornale italiano di cardiologia. 1994;24(2):151-154.
158. Bonde P, Sachithanandan A., Graham A. N. [et al.]. Right atrial myxoma arising from the Eustachian valve in a patient with colonic polyposis. The Journal of heart valve disease. 2002;11(4):601-602.
159. Shigemitsu O., Hadama T., Mori Y. [et al.]. Ruptured abdominal aortic aneurysms: Perioperative management and operative method. Cardiovascular Surgery. 1995;3: 76-76. https://doi.org/10.1016/0967-2109(95)94188-3
160. Nkomo V. T., Miller F. A. Eustachian valve cyst. Journal of the American Society of Echocardiography. 2001;14(12):1224-1226. https://doi.org/10.1067/mje.2001.115390
161. Pellicelli A. M., Pino P, Terranova A. [et al.]. Eustachian valve endocarditis: a rare localization of right side endocarditis. A case report and review of the literature. Cardiovascular Ultrasound. 2005;3(1). https://doi.org/10.1186/1476-7120-3-30
162. Roman J. A. S., Vilacosta I., Sarria C. [et al.]. Eustachian valve endocarditis: Is it worth searching for? American Heart Journal. 2001;142(6):1037-1040. https://doi.org/10.1067/mhj.2001.119125
163. Halimi F., Hidden-Lucet F., Tonet J. [et al.]. Journal of Interventional Cardiac Electrophysiology. 1999;3(2):169- 172. https://doi.org/10.1023/a:1009829832500
164. Nakagawa H., Lazzara R., Khastgir T. [et al.]. Role of the Tricuspid Annulus and the Eustachian Valve/Ridge on Atrial Flutter: Relevance to Catheter Ablation of the Septal Isthmus and a New Technique for Rapid Identification of Ablation Success. Circulation. 1996;94(3):407-424. https://doi.org/10.1161/01.cir.94.3.407
165. Schrem S. S., Freedberg R. S., Gindea A. J. [et al.]. The association between unusually large eustachian valves and atrioventricular valvular prolapse. American Heart Journal. 1990;120(1):204-206. https://doi.org/10.1016/0002-8703(90)90179-2
166. Yavuz T., Nazli C., Kinay O. [et al.]. Giant Eustachian valve: with echocardiographic appearance of divided right atrium. Texas Heart Institute Journal. 2002;29(4):336.
167. Martinez-Quintana E., Rodriguez-Gonzalez F., Marrero-Santiago H. [et al.]. Cor Triatriatum Dexter versus Prominent Eustachian Valve in an Adult Congenital Heart Disease Patient. Congenital Heart Disease. 2012;8(6):589-591. https://doi.org/10.111Vj.1747-0803.2012.00648.x
168. Roberson D. A., Javois A. J., Cui W. [et al.]. Double Atrial Septum with Persistent Interatrial Space: Echocardiographic Features of a Rare Atrial Septal Malformation. Journal of the American Society of Echocardiography. 2006;19(9):1175-1181. https://doi.org/10.1016/j. echo.2006.04.001
169. Modi K., Reddy P, Madhusudanannair V. Diagnosis of a Very Rare Variant of Cor Triatriatum Dexter by Contrast Echocardiography: A Case Report. Echocardiography. 2009;26(2):220-223. https://doi.org/10.111Vj.1540-8175.2008.00777.x
170. Seyfert H., Bohlscheid V., Bauer B. Double atrial septum with persistent interatrial space and transient ischaemic attack. European Journal of Echocardiography. 2008;9(5):707-708. https://doi.org/10.1093/ejecho-card/jen161
171. Javois A. J., Roberson D. A. Unusual Atrial Septal Anatomy Resulting in an Interatrial Chamber: The True Triatrial Heart? Pediatric Cardiology. 2007;28(3):224-228. https://doi.org/10.1007/s00246-006-0057-5
172. Becker A., Buss M., Sebening W. [et al.]. Acute Inferior Cardiac Inflow Obstruction Resulting from Inadvertent Surgical Closure of a Prominent Eustachian Valve Mistaken for an Atrial Septal Defect. Pediatric Cardiology. 1999;20(2):155-157. https://doi.org/10.1007/s002469900427
173. Tarnowska A., Werner В., Godlewski K. Difficulties in transcutaneous closure of atrial septal defect-persistent Eustachian valve. Kardiologia polska. 2003;59(9):258- 260.
174. Onorato E., Pera I. G., Melzi G. [et al.]. Persistent redundant Eustachian valve interfering with Amplatzer PFO occluder placement: Anatomico-clinical and technical implications. Catheterization and Cardiovascular Interventions. 2002;55(4):521-524. https://doi.org/10.1002/ccd.10141
175. Ucar O., Canbay A., Diker E. [et al.]. Long Eustachian valve interfering with the access to coronary sinus during biventricular pacemaker implantation. Anadolu Kardiyoloji Der- gisi. The Anatolian Journal of Cardiology. 2010;10(2):185- 186. https://doi.org/10.5152/akd.2010.047
176. Scacciatella P, Butera G., Meynet I. [et al.]. Percutaneous Closure of Patent Foramen Ovale in Patients with Anatomical and Clinical High-Risk Characteristics: Long-Term Efficacy and Safety. Journal of Interventional Cardiology. 2011;24(5):477-484. https://doi.org/10.111Vj.1540-8183.2011.00652.x
177. Ho S. Y. Anatomy of the mitral valve. Heart. 2002;88(4):5- 10. https://doi.org/10.1136/heart.88.suppl_4.iv5
178. Grewal J., Suri R., Mankad S. [et al.]. Mitral Annular Dynamics in Myxomatous Valve Disease: New Insights With Real-Time 3-Dimensional Echocardiography. Circulation. 2010;121(12):1423-1431. https://doi.org/10.1161/cir-culationaha.109.901181
179. Barlow J. B., Bosman C. K., Pocock W. A. [et al.]. Late systolic murmurs and non-ejection («mid-late») systolic clicks. An analysis of 90 patients. Heart. 1968;30(2):203. https://doi.org/10.1136/hrt.30.2.203
180. Carpentier A., Lacourgayet F, Camilleri J. P. [et al.]. Fi- broelastic dysplasia of the mitral-valve-an anatomical and clinical entity. In Circulation. 1980;62(4):207-207.
181. Freed L. A., Acierno J. S., Dai D. [et al.]. A Locus for Autosomal Dominant Mitral Valve Prolapse on Chromosome 11p15.4. The American Journal of Human Genetics. 2003;72(6):1551-1559. https://doi.org/10.1086/375452
182. Nesta F. New Locus for Autosomal Dominant Mitral Valve Prolapse on Chromosome 13: Clinical Insights From Genetic Studies. Circulation. 2005;112(13):2022-2030. https://doi.org/10.1161/circulationaha.104.516930
183. Kyndt F., Gueffet J.-P., Probst V. [et al.]. Mutations in the Gene Encoding Filamin A as a Cause for Familial Cardiac Valvular Dystrophy. Circulation. 2006;115(1):40-49. https://doi.org/10.1161/circulationaha.106.622621
184. Rudoj A. S., Letkovskaja T. A., Uryvaev A. M. [et al.]. Rol’ TGFp-indukcii i gastrointestinal’nyh miofibroblastov v patomorfogeneze hronicheskogo gastrita u pacientov s sindromom Marfana i marfanopodobnymi sostojani- jami. Jeksperimental’naja i klinicheskaja gastrojenter- ologija. - Experimental and clinical gastroenterology. 2016;(6):14-18. (In Russ.)
185. Gromova O. A. Moleku- ljarnye mehanizmy vozdejstvija magnija na displaziju soe- dinitel’noj tkani. Displ. soedinit. tkan. - Connective tissue dysplasia. 2008;1:25-34. (In Russ.)
186. Klemenov A. V. Prolaps mitral’nogo klapana. Izd. 2-e, pererab. i dop. M.: «ID Medpraktika-M», 2005. (In Russ.)
187. Schneider A., Sorrentino M. Definition and diagnosis of mitral valve prolapse 2013. Available at: http://medicine.ucsf.edu/education/resed/Chiefs_cover_sheets/mvp.pdf
188. Shah P. M. Current concepts in mitral valve prolapse- Diagnosis and management. Journal of Cardiology. 2010;56(2):125-133. https://doi.org/10.1016/j.jjcc.2010.06.004
189. Braunwald E., Bonow R., Mann D. [et al.]. Foreword. Preventive Cardiology: Companion to Braunwald’s Heart Disease. 2011. xiii. https://doi.org/10.1016/b978-1- 4377-1366-4.00039-1
190. Bonow R. O., Carabello B. A., Chatterjee K. [et al.]. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease. Journal of the American College of Cardiology. 2008;52(13):e1-e142. https://doi.org/10.1016/j.jacc.2008.05.007
191. Otto C. M., Bonow R. O. Valvular Heart Disease. Braun- wald’s Heart Disease: A Textbook of Cardiovascular Medicine. 2012;1468-1539. https://doi.org/10.1016/b978-1-4377-0398-6.00066-4
192. Otto C. M., Bonow R. O. Preface. Valvular Heart Disease: A Companion to Braunwald’s Heart Disease. 2009;452. https://doi.org/10.1016/b978-1-4160-5892-2.00045-3
193. Grau J., Pirelli L., Yu P.-J. [et al.]. The genetics of mitral valve prolapse. Clinical Genetics. 2007;72(4):288-295. https://doi.org/10.1111/j.1399-0004.2007.00865.x
194. Pellerin D., Brecker S., Veyrat C. Degenerative mitral valve disease with emphasis on mitral valve prolapse. Heart. 2002;88(4):20iv-28. https://doi.org/10.1136/heart.88.suppl_4.iv20
195. Anyanwu A. C., Adams D. H. Etiologic Classification of Degenerative Mitral Valve Disease: Barlow’s Disease and Fibroelastic Deficiency. Seminars in Thoracic and Cardiovascular Surgery. 2007;19(2):90-96. https://doi.org/10.1053/j.semtcvs.2007.04.002
196. Adams D. H., Rosenhek R., Falk, V. Degenerative mitral valve regurgitation: best practice revolution. European Heart Journal. 2010;31(16):1958-1966. https://doi.org/10.1093/eurheartj/ehq222
197. Guy T. S., Hill A. C. Mitral Valve Prolapse. Annual Review of Medicine. 2012;63(1):277-292. https://doi.org/10.1146/ annurev-med-022811-091602
198. Griffin B. P. Myxomatous Mitral Valve Disease. Valvular Heart Disease: A Companion to Braunwald’s. Heart Disease. 2009;243-259. https://doi.org/10.1016/b978-1-4160-5892-2.00015-5
199. Malev E. G. Rasprostranennost, patogeneticheskiye mekhanizmy i osobennosti vedeniya patsiyentov s prolapsom mitralnogo klapana. 2014. (In Russ.)
200. Theal M., Sleik K., Anand S. [et al.]. Prevalence of mitral valve prolapse in ethnic groups. The Canadian journal of cardiology. 2004;20(5):511-515.
201. Devereux R. B., Jones E. C., Roman M. J. [et al.]. Prevalence and correlates of mitral valve prolapse in a population-based sample of American Indians: the strong heart study. The American Journal of Medicine. 2001;111(9):679-685. https://doi.org/10.1016/s0002-9343(01)00981-0
202. Flack J. M., Kvasnicka J. H., Gardin J. M. [et al.]. Anthropometric and physiologic correlates of mitral valve prolapse in a biethnic cohort of young adults: The CARDIA study. American Heart Journal. 1999;138(3):486-492. https://doi.org/10.1016/s0002-8703(99)70151-1
203. Zemcovskij Je. V. Sportivnaja kardiologija. SPb: «Gippokrat», 1995. (In Russ.)
204. Rudoj A. S. Rasprostranennost’ i aktual’nye voprosy voenno-vrachebnoj jekspertizy prolapsa mitral’nogo klapana. Voennaja medicina. - Military medicine. 2011;1:36-41. (In Russ.)
205. Freed L. A., Benjamin E. J., Levy D. [et al.]. Mitral valve prolapse in the general population. Journal of the American College of Cardiology. 2002;40(7):1298-1304. https://doi.org/10.1016/s0735-1097(02)02161-7
206. Malev Je. G., Reeva S. V., Timofeev E. V. [et al.]. Sovremennye podhody k diagnostike i ocenke rasprostranennosti prolapsa mitral’nogo klapa- na u lic molodogo vozrasta. Rossijskij kardiologicheskij zhurnal. - Russian Cardiology Journal. 2010;1:35-41. (In Russ.)
207. Levine R. A., Handschumacher M. D., Sanfilippo A. J. [et al.]. Three-dimensional echocardiographic reconstruction of the mitral valve, with implications for the diagnosis of mitral valve prolapse. Circulation. 1989;80(3):589-598. https://doi.org/10.1161/01.cir.80.3.589
208. Bonow R. O., Carabello B. A., Chatterjee K. [et al.]. ACC/ AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology. American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Developed in Collaboration With the Society of Cardiovascular Anesthesiologists: Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006;114(5):e84-e231. https://doi.org/10.1161/circulationaha.106.176857
209. Rudoj A. S. Zabolevanija verhnih otdelov zhelu- dochno-kishechnogo trakta u lic molodogo vozrasta, as- sociirovannye s nasledstvennymi narushenijami soedini- tel’noj tkani (osobennosti klinicheskoj kartiny, jetiologii, patomorfogeneza i prognoza klinicheskogo techenija): avtoref. dis. ... d-ra med. nauk. SPb., 2009. (In Russ.)
210. Glotov A. V., Minie- vich O. L. Sosudisto-trombocitarnyj gemostaz pri displa- zii soedinitel’noj tkani i zabolevanijah, associirovannyh s nej. Omskij nauchnyj vestnik. - Omsk Scientific Bulletin. 2005;1(30):107-110. (In Russ.)
211. Yagoda A. V., Gladkikh N. N., Gladkikh L. N. The specifics of adhesion function of endothelium in various clinical variants of primary mitral valve prolapse. Kardiovaskulyarnaya terapiya i profilaktika. - Cardiovascular Therapy and Prevention. 2016;15(1):45-50. (In Russ.) https://doi.org/10.15829/1728-8800-2016-1-45-50
212. Gladkih, N. N. Prolaps mitral’nogo klapana: kliniko-patogeneticheskij analiz s pozicii displazii soedinitel’noj tkani. 2009;40. (In Russ.)
213. Kleme- nov A. V. Sindrom vegetativnoj distonii u junoshej s prolap- som mitral’nogo klapana. Medicinskii vestnik Severnogo Kavkaza. - Medical News of North Caucasus. 2008;10(2). (In Russ.)
214. Bourdarias J. P. Mitral valve prolapse: a severe abnormality? Archives des maladies du coeur et des vaisseaux. 1991;84(7):981-986.
215. DeGuire S., Gevirtz R., Kawahara Y. [et al.]. Hyperventilation syndrome and the assessment of treatment for functional cardiac symptoms. The American Journal of Cardiology. 1992;70(6):673-677. https://doi.org/10.1016/0002-9149(92)90211-g
216. Wikiecho. Available at: www.wikiecho.org/wiki/File: Accessed January 29, 2016.
217. Yagoda A. V., Prutkova N. A., Gladkix N. N. Pervichnyj prolaps mitral’nogo klapana u vzroslyx. Diagnostika, voprosy dispanserizacii i vrachebnoj e’kspertizy. Uchebnoe posobie. Stavropol: «SGMA», 2007. (In Russ.)
218. Ikeda T Mitral valve prolapse in idiopathic ventricular tachycardia: Clinical and electrophysiologic characteristics. Journal of cardiology. 1991;21(3):717-726.
219. Kavey R.-E. W., Blackman M. S., Sondheimer H. M. [et al.]. Ventricular arrhythmias and mitral valve prolapse in childhood. The Journal of Pediatrics. 1984;105(6):885- 890. https://doi.org/10.1016/s0022-3476(84)80071-2
220. Loeys B. L., Dietz H. C., Braverman A. C. [et al.]. The revised Ghent nosology for the Marfan syndrome. Journal of Medical Genetics. 2010;47(7):476-485. https://doi.org/10.1136/jmg.2009.072785
221. Stoddard M. F, Prince C. R., Dillon S. [et al.]. Exercise-induced mitral regurgitation is a predictor of morbid events in subjects with mitral valve prolapse. Journal of the American College of Cardiology. 1995;25(3):693-699. https://doi.org/10.1016/0735-1097(94)00408-i
222. Farb A., Tang A. L., Atkinson J. B. [et al.]. Comparison of cardiac findings in patients with mitral valve prolapse who die suddenly to those who have congestive heart failure from mitral regurgitation and to those with fatal noncardiac conditions. The American Journal of Cardiology. 1992;70(2):234-239. https://doi.org/10.1016/0002-9149(92)91281-8
223. Habib G., Lancellotti P., Antunes M. J. [et al.]. 2015 ESC Guidelines for the management of infective endocarditis. European Heart Journal. 2015;36(44):3075-3128. https://doi.org/10.1093/eurheartj/ehv319
224. Pocock W. A., Bosman C. K., Chesler E. [et al.]. Sudden death in primary mitral valve prolapse. American Heart Journal. 1984;107(2):378-382. https://doi.org/10.1016/0002-8703(84)90389-2
225. Allen H., Harris A., Leatham A. Significance and prognosis of an isolated late systolic murmur: a 9- to 22-year- yearfollow-up. Heart. 1974;36(6):525-532. https://doi.org/10.1136/hrt.36.6.525
226. Mills P., Rose J., Hollingsworth J. [et al.]. Long-Term Prognosis of Mitral-Valve Prolapse. New England Journal of Medicine. 1977;297(1):13-18. https://doi.org/10.1056/ nejm197707072970103
227. Fontana M. E., Wooley C. F, Sparks E. A., Boudoulas H. Mitral valve prolapse and the mitral valve prolapse syndrome. Current Problems in Cardiology. 1991;16(5),313- 375. https://doi.org/10.1016/0146-2806(91)90022-3
228. Richard B., Devereux W. Ted Brown, Randi Kramer- Fox M. S. [et al.]. Inheritance of Mitral Valve Prolapse: Effect of Age and Sex on Gene Expression. Annals of Internal Medicine. 1982;97(6):826. https://doi.org/10.7326/0003-4819-97-6-826
229. Avierinos J.-F Natural History of Asymptomatic Mitral Valve Prolapse in the Community. Circulation. 2002;106(11):1355-1361. https://doi.org/10.1161/01.cir.0000028933.34260.09
230. Devereux R. B., Frary C. J., Kramer-Fox R. [et al.]. Cost-effectiveness of infective endocarditis prophylaxis for mitral valve prolapse with or without a mitral regurgitant murmur. The American Journal of Cardiology. 1994;74(10):1024- 1029. https://doi.org/10.1016/0002-9149(94)90853-2
231. Storozhakov G. I., Vereshchagina G. S., Malysheva N. V. Stratifikatsiya riska i vybor klinicheskoy taktiki u patsiyentov s prolapsom mitralnogo klapana. Serdechnaya nedostatochnost. - Heart failure. 2001;1(6):287-290. (In Russ.)
232. Buchner S., Hulsmann M., Poschenrieder F [et al.]. Variable phenotypes of bicuspid aortic valve disease: classification by cardiovascular magnetic resonance. Heart. 2010;96(15):1233-1240. https://doi.org/10.1136/ hrt.2009.186254
233. Crawford M. H. Current Diagnosis & Treatment in Cardiology. 2nd ed. NY: McGraw_Hill Companies, 2002.
234. Maruo A. Ruptured sinus of Valsalva aneurysm associated with aortic regurgitation caused by hemodynamic effect solely. European Journal of Cardio-Thoracic Surgery. 2003;24(2):318-319. https://doi.org/10.1016/s1010- 7940(03)00259-8
235. De Kerchove L., Glineur D., Poncelet A. [et al.]. Repair of aortic leaflet prolapse: a ten-year experience. European Journal of Cardio-Thoracic Surgery. 2008;34(4):785- 791. https://doi.org/10.1016Zj.ejcts.2008.06.030
236. Ribeiro C. L., Ginefra P, Albanesi F. F. [et al.]. Prevalence of tricuspid and aortic valve prolapse in patients with mitral valve prolapse. Arquivos brasileiros de cardiologia. 1989;53(5):251-255.
237. Shapiro L. M., Thwaites B., Westgate C. [et al.]. Prevalence and clinical significance of aortic valve prolapse. Heart. 1985;54(2):179-183. https://doi.org/10.1136/ hrt.54.2.179
238. Morganroth J., Jones R. H., Chen C. C. [et al.]. Two dimensional echocardiography in mitral, aortic and tricuspid valve prolapse. The American Journal of Cardiology. 1980;46(7):1164-1177. https://doi.org/10.1016/0002-9149(80)90287-8
239. Boodhwani M., de Kerchove L., Glineur D. [et al.]. Repair of aortic valve cusp prolapse. Multimedia Manual of Cardio-Thoracic Surgery. 2009;(0702). https://doi.org/10.1510/mmcts.2008.003806
240. Le Polain de Waroux J.-B., Pouleur A.-C., Goffinet C. [et al.]. Functional Anatomy of Aortic Regurgitation: Accuracy, Prediction of Surgical Repairability, and Outcome Implications of Transesophageal Echocardiography. Circulation. 2007;116(11):I-264-I-269. https://doi.org/10.1161/ circulationaha.106.680074
241. Elkhoury G. Repair of aortic valve prolapse: experience with 44 patients. European Journal of Cardio-Thoracic Surgery. 2004;26(3):628-633. https://doi.org/10.1016/j.ejcts.2004.05.027
242. Allen M. N. Echocardiography. Philadelphia: Lippincott Williams & Wilkins, 1999.
243. Zemcovskij Je.V. Displasticheskie sindromy i fenotipy. Displasticheskoe serdce. SPb: «Ol’ga», 2007. (In Russ.)
244. Otto C. M. Valvular Heart Disease. 2nd ed. Philadelphia: Saunders, 2004.
245. Schafers H.-J., Langer F., Glombitza P [et al.]. Aortic valve reconstruction in myxomatous degeneration of aortic valves: Are fenestrations a risk factor for repair failure? The Journal of Thoracic and Cardiovascular Surgery. 2010;139(3):660-664. https://doi.org/10.1016/j.jtcvs.2009.06.025
246. Authors/Task Force Members, Vahanian A., Alfieri O., An- dreotti F [et al.]. Guidelines on the management of valvular heart disease (version 2012) The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European heart journal. 2012;33(19):2451-2496.
247. Fukuda S. Three-Dimensional Geometry of the Tricuspid Annulus in Healthy Subjects and in Patients With Functional Tricuspid Regurgitation: A Real-Time, 3-Dimensional Echocardiographic Study. Circulation. 2006;114(1):I-492-I-498. https://doi.org/10.1161/circu-lationaha.105.000257
248. Lancellotti P, Moura L., Pierard L. A. [et al.]. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). European Journal of Echocardiography. 2010;11(4):307-332. https://doi.org/10.1093/ejechocard/jeq031
249. Rogers J. H., Bolling S. F The Tricuspid Valve: CurrentьPerspective and Evolving Management of Tricuspid Regurgitation. Circulation. 2009;119(20):2718-2725. https://doi.org/10.1161/circulationaha.108.842773
250. laizzo P A. Handbook of cardiac anatomy, physiology, and devices. Springer Science & Business Media. 2009.
251. Davies A. O., Mares A., Pool J. L. [et al.]. Mitral valve prolapse with symptoms of beta-adrenergic hypersensitivity. The American Journal of Medicine. 1987;82(2):193-201. https://doi.org/10.1016/0002-9343(87)90055-6
252. Trisvetova E. L. Malye anomalii serdca: (Klinika, diagnostika, jekspertnoe znachenie dlja muzhchin molodogo vozrasta). 2004. (In Russ.)
253. Waller B. F, Moriarty A. T., Eble J. N. [et al.]. Etiology of pure tricuspid regurgitation based on anular circumference and leaflet area: Analysis of 45 necropsy patients with clinical and morphologic evidence of pure tricuspid regurgitation. Journal of the American College of Cardiology. 1986;7(5):1063-1074. https://doi.org/10.1016/s0735-1097(86)80224-8
254. Sattur S., Bates S., Movahed M. R. Prevalence of mitral valve prolapse and associated valvular regurgitations in healthy teenagers undergoing screening echocardiography. Experimental & Clinical Cardiology. 2010;15(1):e13.
255. Van Son J. A. M., Miles C. M., Starr A. Tricuspid valve prolapse associated with myxomatous degeneration. The Annals of Thoracic Surgery. 1955;59(5):1237-1239. https://doi.org/10.1016/0003-4975(94)00968-d
256. Malev Je. G., Zemcovskij Je. V. Prolapsy trikuspidal’nogo, aortal’nogo i pul’monal’nogo klapanov. Ul'trazvukovaja i funkcional'naja diagnostika. - Ultrasonic and functional diagnostics. 2011;3:84- 92. (In Russ.)
257. Prabhu M. Trans-esophageal echocardiography for tricuspid and pulmonary valves. Annals of Cardiac Anaesthesia. 2009;12(2):174. doi:10.4103/0971-9784.53439
258. Taylor М. А. Tricuspid Valve and Pulmonic Valve. Available at: www.scahq.org/sca3/events/2012/echo/fundamentals/submissions/tue/Tricus-pid%20Valve%20and%20Pulmonic%20Valve%20-%20Taylor.pdf Accessed January 27, 2016.
259. Fornes P, Heudes D., Fuzellier J.-F. [et al.]. Correlation Between Clinical and Histologic Patterns of Degenerative Mitral Valve Insufficiency. Cardiovascular Pathology. 1999;8(2):81-92. https://doi.org/10.1016/s1054- 8807(98)00021-0
260. Raichlen J. S., Brest A. N. Tricuspid valve prolapse. Cardiovasc. Clin. 1987;17(2):97-109.
261. Zemcovskij Je. V. Displasticheskie sindromy i fenotipy. Displasticheskoe serdce. SPb: «Ol’ga», 2007. (In Russ.)
262. McCarthy P M., Bhudia S. K., Rajeswaran J. [et al.]. Tricuspid valve repair: durability and risk factors for failure. The Journal of Thoracic and Cardiovascular Surgery. 2004;127(3):674-685. https://doi.org/10.1016/j.jtcvs.2003.11.019
263. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(writing Committee to Revise the 1998 guidelinesfor the management of patients with val- vularheart disease) developed in collaboration with the- Society of Cardiovascular Anesthesiologists endorsed by the Society for CardiovascularAngiography and Interventions and the Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 2006;48(3):1-148.
264. Authors/Task Force Members, Vahanian A., Alfieri, O., Andreotti F, Antunes M. J. [et al.]. Guidelines on the management of valvular heart disease (version 2012) The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European heart journal. 2012;33(19):2451-2496.
265. Anatomija malyh anomalij serdca. Minsk: «Belprint», 2006. (In Russ.)
266. Lancellotti P, Tribouilloy C., Hagendorff A. [et al.]. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). European Journal of Echocardiography. 2010;11(3):223-244. https://doi.org/10.1093/ejechocard/jeq030
267. Virtual Transesophageal Echocardiography. Toronto General Hospital Department of Anesthesia and Pain Management. Available at: http: // pie.med.utoronto.ca/ TEE/index.htm. Accessed January 27, 2016.
268. De Backer J., Loeys B., Devos D. [et al.]. A critical analysis of minor cardiovascular criteria in the diagnostic evaluation of patients with Marfan syndrome. Genetics in Medicine. 2006;8(7):401-408. https://doi.org/10.1097/01.gim.0000223550.41849.e3
269. De backer J. Cardiovascular characteristics in Marfan syndrome and their relation to the genotype. Verh. K. Acad. Geneeskd. Belg. 2009;71(6):335-371.
270. Oosterhof T, Hazekamp M. G., Mulder В. J. Opportunities in pulmonary valve replacement. Expert Review of Cardiovascular Therapy. 2009;7(9):1117-1122. https://doi.org/10.1586/erc.09.89
271. Zemcovskij Je. V., Krasovska- ya Yu. V., Parfenova N. N. [i dr.]. Asimmetriya smykaniya aortalnykh poluluny - ekhokardiografichesky fenomen ili klinicheski znachimaya anomaliya serdtsa? Kardiologiya SNG. - Cardiology of the CIS. 2006;3(2):135-140 (In Russ.)
272. Mookadam F., Thota V. R., Lopez A. M. [et al.]. Unicuspid aortic valve in children: a systematic review spanning four decades. J. Heart Valve Dis. 2010;19(6):678-683.
273. Friedman T, Mani A., Elefteriades J. A. Bicuspid aortic valve: clinical approach and scientific review of a common clinical entity. Expert Review of Cardiovascular Therapy. 2008;6(2):235-248. https://doi.org/10.1586/14779072.6.2.235
274. Roberts W. C., Ko J. M. Weights of individual cusps in operatively-excised stenotic three-cuspid aortic valves. The American Journal of Cardiology. 2004;94(5):681-684. https://doi.org/10.1016/j.amjcard.2004.05.045
275. Tutarel O. Quadricuspid aortic valves: A review. Clinical Cardiology. 2003;26(5):A24-A24. https://doi.org/10.1002/clc.4960260513
276. Gnusaev S. F., Belozerov Ju. M. Jehokardiograficheskie kriterii diagnostiki i klassifikacii malyh anomalij serdca u detej. Ul'trazvukovaja diagnos- tika. - Ultrasound diagnostics. 1997;3:21-27. (In Russ.)
277. Clinical significance of transverse pericardial - coronary artery // 78 steps Health Journal. Available at: www.78stepshealth.us/coronary-artery/s-fje.html Accessed January 24, 2016.
278. Vollebergh F. E., Becker A. E. Minor congenital variations of cusp size in tricuspid aortic valves. Possible link with isolated aortic stenosis. Heart. 1977;39(9):1006-1011. https://doi.org/10.1136/hrt.39.9.1006
279. Krasovskaja Ju. V. Asim- metrija trehstvorchatogo klapana kak malaja anomali- ja serdca. Avtoref. dis. ... kand. med. nauk. SPb, 2007. (In Russ.)
280. Parfenova N. N. Kliniko- ul’trazvukovye sopostavlenija u lic molodogo vozrasta s sindromom displazii soedinitel’noj tkani serdca: avtoref. dis. ... kand. med. nauk. SPb, 2002. (In Russ.)
281. Pavlovskij V. A., Chechitova Ju. S., Parfenova N. N. [et al.]. Matemati- cheskoe modelirovanie mehanicheskogo stressa, vozni- kajushhego v processe funkcionirovanija asimmetrichnyh stvorok aortal’nogo klapana. Vestnik Sankt-Peterburgs- kogo universiteta. Serija 10: Prikladnaja matemati- ka. Informatika. Processy upravlenija. - Bulletin of St. Petersburg University. 2008;4:72-79. (In Russ.)
282. Sergovencev A. A. Kal’cinirovannyj aortal’nyj stenoz: itogi 15-letnego izuchenija v Rossii. RMZh (Kardiologija). - Russian Medical Journal (Cardiology). 2013;27. (In Russ.)
283. Mitrofanova L. B., Koval’skij G. B. Morfologicheskaja harakteristika i dif- ferencial’naja diagnostika zabolevanij klapanov serdca. Arhiv patologii. - Archive of pathology. 2007;69(1):24- 31. (In Russ.)
284. Otto C. M. Calcification of bicuspid aortic valves. Heart. 2002;88(4):321-322. https://doi.org/10.1136/ heart.88.4.321
285. Gilon D., Cape E. G., Handschumacher M. D. [et al.]. Effect of three-dimensional valve shape on the hemodynamics of aortic stenosis. Journal of the American College of Cardiology. 2002;40(8):1479-1486. https://doi.org/10.1016/s0735-1097(02)02269-6
286. Fernandes S. M., Sanders S. P, Khairy P. [et al.]. Morphology of bicuspid aortic valve in children and adolescents. Journal of the American College of Cardiology. 2004;44(8):1648-1651. https://doi.org/10.1016/j.jacc.2004.05.063
287. Hasanova S.I. Rol’ soedinitel’notkannoj displazii v formirovanii sklero-degenerativnyh porazhenij aortal’nogo klapana. Dis. kand. med. nauk. 2010. (In Russ.)
288. Zemcovskij Je.V., Parfenova N.N., Krasovskaja Ju.V. [et al.]. Raschet asimmetrii treh-stvorchatogo aortal’nogo klapana. Svidetel’stvo ob oficial’noj registracii programmy dlja JeVM №2007615221. (In Russ.)
289. Calleja A., Thavendiranathan P., Ionasec R. I. [et al.]. Automated Quantitative 3-Dimensional Modeling of the Aortic Valve and Root by 3-Dimensional Transesophageal Echocardiography in Normals, Aortic Regurgitation, and Aortic Stenosis: Comparison to Computed Tomography in Normals and Clinical Implications. Circulation: Cardiovascular Imaging. 2012;6(1):99-108. https://doi.org/10.1161/circimaging.112.976993
290. Zemcovskij Je. V., Krasovskaja Ju. V., Parfenova N. N. [et al.]. Kriterii diagnostic i klinicheskaja ocenka asimmetrii terhstvorchatogo aortal’nogo klapana. Ter. Arhiv. - Therapeutic archive. 2006;12:50-55. (In Russ.)
291. Parfenova N. N., Krasovskaja Ju. V., Hasanova S. I. [et al.]. Asimmetrija aortal’nyh polulunij - kriterii jehokardiograficheskoj diagnostiki. Vestnik Sankt-Peter- burgskogo universiteta. Serija 11: Medicina. - Bulletin of St. Petersburg University. 2010;1:30-38. (In Russ.)
292. Authors/Task Force Members, Vahanian A., Alfieri O., An- dreotti F. [et al.]. Guidelines on the management of valvular heart disease (version 2012) The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European heart journal. 2012;33(19):2451-2496.
293. Gareri P., Merante A., Castagna A. [et al.]. Transient cerebral ischemia in an elderly patient with patent foramen ovale and atrial septal aneurysm. Clinical Interventions in Aging. 2015;1445. https://doi.org/10.2147/cia.s80190
294. Mas J.-L., Arquizan C., Lamy C. [et al.]. Recurrent Cerebrovascular Events Associated with Patent Foramen Ovale, Atrial Septal Aneurysm, or Both. New England Journal of Medicine. 2001;345(24):1740-1746. https://doi.org/10.1056/nejmoa011503
295. Mattioli A. Atrial septal aneurysm as a cardioembolic source in adult patients with stroke and normal carot id arteries. A multicentre study. European Heart Journal. 2001;22(3):261-268. https://doi.org/10.1053/euhj.2001.2293
296. Rigatelli G., Aggio S., Cardaioli P [et al.]. Left Atrial Dysfunction in Patients With Patent Foramen Ovale and Atrial Septal Aneurysm. JACC: Cardiovascular Interventions. 2009;2(7):655-662. https://doi.org/10.1016/j.jcin.2009.05.010
297. Van Son J. A. M., Miles C. M., Starr A. Tricuspid valve prolapse associated with myxomatous degeneration. The Annals of Thoracic Surgery. 1995;59(5):1237-1239. https://doi.org/10.1016/0003-4975(94)00968-d
298. Emine B. S., Murat A., Mehmet B. [et al.]. Flail mitral and tricuspid valves due to myxomatous disease. European Journal of Echocardiography. 2007;9(2):304-305.
299. Kyndt F., Gueffet J.-P., Probst V. [et al.]. Mutations in the Gene Encoding Filamin A as a Cause for Familial Cardiac Valvular Dystrophy. Circulation. 2007;115(1):40-49. https://doi.org/10.1161/circulationaha.106.622621
300. Onishenko E. F. Kliniko-jehokardiograficheskaja harakteristika vnutripolostnyh struktur serdca v norme i pri patologii. Dis. d.m.n. SPb, 2000. (In Russ.)
301. Blankenship J. C. Migraine and patent foramen ovale: Headache for patient and cardiologist. Catheterization and Cardiovascular Interventions. 2010;75(4):505-506. https://doi.org/10.1002/ccd.22489
302. Gersony W. M., Gersony D. R. Migraine Headache and the Patent Foramen Ovale. Circulation. 2010;121(12):1377- 1378. https://doi.org/10.1161/cir.0b013e3181daf630

Keywords: heart, structural anomalies, connective tissue, heritable disorders, guidelines


Founders:
Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy